SynthesisThe journal of headache and pain2022

Relative efficacy of lasmiditan versus rimegepant and ubrogepant as acute treatments for migraine: network meta-analysis findings.

Pepa Polavieja et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.